Onward Medical N.V. (ONWRY)

Market Cap	140.37M -31.5%
Revenue (ttm)	9.62M +210.1%
Net Income	-51.72M
EPS	-0.96
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	2.110
Previous Close	2.110
Day's Range	2.110 - 2.110
52-Week Range	2.110 - 5.760
Beta	0.81
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven move...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 137
• Stock Exchange: OTCMKTS
• Ticker Symbol: ONWRY

Financial Performance

In 2025, Onward Medical's revenue was 5.41 million, an increase of 211.33% compared to the previous year's 1.74 million. Losses were -41.79 million, 17.0% more than in 2024.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Alpha Vantage

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Alpha Vantage.

Last checked:

Nov 10, 2026

Data Sources Report a data error